Kenai Therapeutics
PrivateLast Round
Grant
Jan 5, 2026
Total Funding Raised
$12M
Momentum Score
50 /100
Company Overview
Kenai Therapeutics is a biotechnology company focused on developing off-the-shelf neuron replacement therapies as effective disease-modifying treatments for neurological disorders, providing innovative solutions for conditions such as Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kenai Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Kenai Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 5, 2026 | ||||
| Series A | Feb 29, 2024 | ||||
| Grant | Feb 14, 2023 | ||||
| Seed | Jul 6, 2022 |
Key People
Founding team and executive leadership
Kenai Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series A |
| Saisei Ventures | Series A, Seed |
| The Chernin Group | Series A |
| Alaska Permanent Fund | Series A |
| California Institute for Regenerative Medicine | Grant |
| Cure Ventures | Series A |
| Euclidean Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
Allen Waldrop appointed to the Board of Directors.
- Feb 24, 2026
Blake Arnold appointed as new Chief Business Officer.
Kenai Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kenai Therapeutics's valuation, stock price, and market status.
